Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients
- PMID: 17007027
- PMCID: PMC4088175
- DOI: 10.3748/wjg.v12.i35.5711
Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients
Abstract
Aim: To investigate reactivated Epstein-Barr virus (EBV) infection as a cause for chronic hepatitis.
Methods: Patients with occasionally established elevated serum aminotransferases were studied. HIV, HBV and HCV-infections were excluded as well as any other immunosuppressive factors, metabolic or toxic disorders. EBV viral capsid antigen (VCA) IgG and IgM, EA-R and EA-D IgG and Epstein-Barr nuclear antigen (EBNA) were measured using IFA kits. Immunophenotyping of whole blood was performed by multicolor flow cytometry. CD8(+) T cell responses to EBV and PHA were determined according to the intracellular expression of IFN-gamma.
Results: The mean alanine aminotransferase (ALT) and gamma glutamyl transpeptidase (GGTP) values exceeded twice the upper normal limit, AST/ALT ratio < 1. Serology tests showed reactivated EBV infection in all patients. Absolute number and percentages of T, B and NK cells were within the reference ranges. Fine subset analysis, in comparison to EBV(+) healthy carriers, revealed a significant decrease of naive T cells (P < 0.001), accompanied by increased percentage of CD45RA(-) (P < 0.0001), and terminally differentiated CD28(-)CD27(-)CD8(+) T cells (P < 0.01). Moderately elevated numbers of CD38 molecules on CD8(+) T cells (P < 0.05) proposed a low viral burden. A significantly increased percentage of CD8(+) T cells expressing IFN-gamma in response to EBV and PHA stimulation was registered in patients, as compared to controls (P < 0.05). Liver biopsy specimens from 5 patients revealed nonspecific features of low-grade hepatitis.
Conclusion: Chronic hepatitis might be a manifestation of chronic EBV infection in the lack of detectable immune deficiency; the expansion of CD28(-)CD27(-) and increase of functional EBV-specific CD8(+) T cells being the only surrogate markers of viral activity.
Figures


Similar articles
-
Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.J Rheumatol. 2005 Feb;32(2):239-51. J Rheumatol. 2005. PMID: 15693083
-
Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.Leuk Lymphoma. 2015 Apr;56(4):1072-8. doi: 10.3109/10428194.2014.938326. Epub 2014 Aug 13. Leuk Lymphoma. 2015. PMID: 24975317
-
Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.J Immunotoxicol. 2013 Oct-Dec;10(4):387-92. doi: 10.3109/1547691X.2012.758199. Epub 2013 Feb 18. J Immunotoxicol. 2013. PMID: 23418935
-
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.Semin Cancer Biol. 2008 Dec;18(6):397-408. doi: 10.1016/j.semcancer.2008.10.008. Epub 2008 Oct 25. Semin Cancer Biol. 2008. PMID: 18977445 Review.
-
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.Immunol Rev. 2019 Sep;291(1):174-189. doi: 10.1111/imr.12791. Immunol Rev. 2019. PMID: 31402499 Review.
Cited by
-
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.Immunology. 2011 Sep;134(1):17-32. doi: 10.1111/j.1365-2567.2011.03470.x. Epub 2011 Jun 29. Immunology. 2011. PMID: 21711350 Free PMC article. Review.
-
Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity.Blood. 2014 Aug 28;124(9):1450-9. doi: 10.1182/blood-2014-03-563940. Epub 2014 Jul 18. Blood. 2014. PMID: 25037628 Free PMC article.
-
Epstein-Barr virus: silent companion or causative agent of chronic liver disease?World J Gastroenterol. 2010 Sep 7;16(33):4130-4. doi: 10.3748/wjg.v16.i33.4130. World J Gastroenterol. 2010. PMID: 20806428 Free PMC article. Review.
-
EBV Chronic Infections.Mediterr J Hematol Infect Dis. 2010 Aug 10;2(1):e2010022. doi: 10.4084/MJHID.2010.022. Mediterr J Hematol Infect Dis. 2010. PMID: 21415952 Free PMC article.
-
Liver involvement in systemic infection.World J Hepatol. 2014 Sep 27;6(9):632-42. doi: 10.4254/wjh.v6.i9.632. World J Hepatol. 2014. PMID: 25276279 Free PMC article. Review.
References
-
- Rickinson AB, Kieff E. Epsterin-Barr virus. In: Knipe DM, Howley PM, editors. Field's Virology, 4th ed, Vol.2. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2575–2627.
-
- Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481–492. - PubMed
-
- Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280–286. - PubMed
-
- Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527–533. - PubMed
-
- Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988;157:405–412. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials